Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,894,000 | 1,981,000 | 2,004,380 | 2,344,000 | 3,782,000 |
| Marketable Securities | 1,022,000 | 1,009,000 | 1,034,601 | 1,043,000 | 997,000 |
| Inventories | 2,758,000 | 2,554,000 | 2,436,187 | 2,493,000 | 2,403,000 |
| Other current assets | 5,300,000 | 5,313,000 | 5,289,379 | 762,000 | 5,470,000 |
| TOTAL | $10,974,000 | $10,857,000 | $10,988,617 | $11,894,000 | $12,652,000 |
| Non-Current Assets | |||||
| PPE Net | 7,215,000 | 7,051,000 | 6,927,795 | 6,795,000 | 6,731,000 |
| Intangibles | 4,644,000 | 4,648,000 | 4,050,103 | 3,873,000 | 3,912,000 |
| Other Non-Current Assets | 3,997,000 | 3,820,000 | 3,578,485 | 3,290,000 | 3,193,000 |
| TOTAL | $15,856,000 | $15,519,000 | $14,556,383 | $13,958,000 | $13,836,000 |
| Total Assets | $26,830,000 | $26,376,000 | $25,545,000 | $25,852,000 | $26,488,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,175,000 | 1,205,000 | 717,636 | 653,000 | 556,000 |
| Accounts payable and accrued liabilities | 4,374,000 | 4,534,000 | 864,635 | 4,611,000 | 4,493,000 |
| Other current liabilities | N/A | N/A | 2,809,297 | N/A | N/A |
| TOTAL | $7,207,000 | $7,442,000 | $7,262,624 | $7,293,000 | $8,248,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,023,000 | 4,786,000 | 4,673,314 | 4,852,000 | 4,878,000 |
| Other Non-Current Liabilities | 2,397,000 | 3,020,000 | 3,010,909 | 3,474,000 | 3,459,000 |
| TOTAL | $8,582,000 | $8,772,000 | $8,637,668 | $9,155,000 | $9,206,000 |
| Total Liabilities | $15,789,000 | $16,214,000 | $15,900,292 | $16,448,000 | $17,454,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,505,000 | 1,503,000 | 1,497,543 | 1,497,000 | 1,496,000 |
| Retained earnings | 7,820,000 | 7,202,000 | 6,963,013 | 6,940,000 | 6,708,000 |
| Other shareholders' equity | 288,000 | 163,000 | 64,822 | -79,000 | -157,000 |
| TOTAL | $10,796,000 | $9,935,000 | $9,382,867 | $9,162,000 | $8,815,000 |
| Total Liabilities And Equity | $26,585,000 | $26,149,000 | $25,283,159 | $25,610,000 | $26,269,000 |